The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
Clinical trial NCT00294359 · COMPLETED
Trial details
- NCT number
- NCT00294359
- Sponsor
- Australasian Gastro-Intestinal Trials Group
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.